Cell-based approaches in medicine, biotechnology and in pharmaceutical research offer unique prospects to cope with future challenges in the field of public health. Stem cell research, autologous cell therapies and tissue engineering are only a few possible key applications. Progress in these fields will depend on the successful implementation of versatile and flexible tools for the gentle manipulation and characterization of cells. In recent years, we and others have introduced microfluidic lab-on-chip systems that include dielectrophoretic elements for the contact-less handling and the analysis of cells. Here, we present results that were obtained by combining our labon-on-chip devices with a low-cost centrifugation stage for the efficient and gentle separation of microparticles and live human cells. Our approach is supposed to overcome limitations that arise from the use of bulky and expensive external pumping stages.
No takes yet. Share an insight, caveat, or question.
Jaeger et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: